v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance at Jan. 31, 2024 $ 10,732 $ 25,539,964 $ (11,000) $ (31,600,305) $ (6,060,609)
Balance (Accounting Standards Update 2020-06 [Member]) at Jan. 31, 2024 (405,305) (405,305)
Balance, shares at Jan. 31, 2024 23 10,732,387        
Stock-based compensation $ 608 2,965,507 2,966,115
Stock-based compensation, shares   607,806        
Exercise of warrants $ 354 383,646 384,000
Exercise of warrants, shares   353,563        
Net loss (5,137,332) (5,137,332)
Sale of preferred stock 2,084,040 11,000 2,095,040
Sale of preferred stock, shares 173.67          
Conversion of convertible notes payable $ 642 1,048,151 1,048,793
Conversion of convertible notes payable, shares   642,406        
Exercise of options $ 737 (737)
Exercise of options, shares   737,000        
Costs related to the sale of preferred stock (59,656) (59,656)
Balance at Jan. 31, 2025 $ 13,073 31,960,915 (37,142,942) (5,168,954)
Balance, shares at Jan. 31, 2025 196.67 13,073,161        
Stock-based compensation $ 75 277,425   277,500
Stock-based compensation, shares   74,567        
Exercise of warrants $ 23 107,977   108,000
Exercise of warrants, shares   22,500        
Net loss (682,888) (682,888)
Balance at Apr. 30, 2025 $ 13,170 32,346,318 (37,825,830) (5,466,342)
Balance, shares at Apr. 30, 2025 196.67 13,170,228        
Balance at Jan. 31, 2025 $ 13,073 31,960,915 (37,142,942) (5,168,954)
Balance, shares at Jan. 31, 2025 196.67 13,073,161        
Stock-based compensation $ 270 1,393,897 1,394,167
Stock-based compensation, shares   269,686        
Exercise of warrants $ 74 283,867 283,941
Exercise of warrants, shares   74,229        
Net loss (3,074,964) (3,074,964)
Issuance of warrants as compensation 60,000 60,000
Conversion of preferred stock into common stock $ 492 (492)
Conversion of preferred stock into common stock, shares (196.67) 491,667        
Issuance of common stock as financing incentive $ 23 (23)
Issuance of common stock as financing incentive, shares   23,332        
Issuance of warrants as financing incentive 51,475 51,475
Reverse split round up $ 7 (7)
Reverse split round up, shares   6,842        
Balance at Jan. 31, 2026 $ 13,939 33,749,632 (40,217,906) (6,454,335)
Balance, shares at Jan. 31, 2026 13,938,917        
Stock-based compensation $ 10 344,990   345,000
Stock-based compensation, shares   10,000        
Net loss (1,511,930) (1,511,930)
Issuance of warrants as compensation 769,828   769,828
Deferred offering costs 133,082   133,082
Balance at Apr. 30, 2026 $ 13,949 $ 34,997,532 $ (41,729,836) $ (6,718,355)
Balance, shares at Apr. 30, 2026 13,948,917